No abstract
Ann Hematol. 2026 Mar 12;105(4):172. doi: 10.1007/s00277-026-06931-3.
NO ABSTRACT
PMID:41817796 | DOI:10.1007/s00277-026-06931-3
Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis
Scritto il 12/03/2026
da Tamir Shragai